These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 420718)

  • 1. Unusual electromyographic findings in a patient with polymyalgia rheumatica.
    Gross MD; Borkin MH; Rupp S
    Arthritis Rheum; 1979 Mar; 22(3):277-80. PubMed ID: 420718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymyalgia rheumatica in biopsy proven giant cell arteritis does not constitute a different subset but differs from isolated polymyalgia rheumatica.
    González-Gay MA; García-Porrúa C; Vázquez-Caruncho M
    J Rheumatol; 1998 Sep; 25(9):1750-5. PubMed ID: 9733456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic giant-cell arteritis with polymyalgia rheumatica, reversible abnormalities of liver function.
    Dickson ER; Maldonado JE; Sheps SG; Cain JA
    JAMA; 1973 Jun; 224(11):1496-8. PubMed ID: 4739952
    [No Abstract]   [Full Text] [Related]  

  • 4. Recognition of giant cell arteritis in patients with polymyalgia rheumatica who have a stroke: a cautionary tale.
    Gutteridge DH; Mastaglia FL
    Intern Med J; 2017 Oct; 47(10):1199-1201. PubMed ID: 28994265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors and predictive models of giant cell arteritis in polymyalgia rheumatica.
    Rodriguez-Valverde V; Sarabia JM; González-Gay MA; Figueroa M; Armona J; Blanco R; Fernández-Sueiro JL; Martínez-Taboada VM
    Am J Med; 1997 Apr; 102(4):331-6. PubMed ID: 9217613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An unusual presentation of polymyalgia rheumatica with severe muscle weakness.
    Radhamanohar M
    Br J Clin Pract; 1992; 46(3):213-4. PubMed ID: 1286029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation of interleukin-6 production and disease activity in polymyalgia rheumatica and giant cell arteritis.
    Roche NE; Fulbright JW; Wagner AD; Hunder GG; Goronzy JJ; Weyand CM
    Arthritis Rheum; 1993 Sep; 36(9):1286-94. PubMed ID: 8216422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary systemic amyloidosis presenting as giant cell arteritis and polymyalgia rheumatica.
    Salvarani C; Gabriel SE; Gertz MA; Bjornsson J; Li CY; Hunder GG
    Arthritis Rheum; 1994 Nov; 37(11):1621-6. PubMed ID: 7980674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of giant cell (temporal) arteritis in a patient 'adequately' treated for polymyalgia rheumatica.
    Rynes RI; Mika P; Bartholomew LE
    Ann Rheum Dis; 1977 Feb; 36(1):88-90. PubMed ID: 843118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Risk factors for the development of vision disorders in polymyalgia rheumatica with giant cell arteritis].
    Bohle W; Stettin A; Jipp P
    Dtsch Med Wochenschr; 2000 Jun; 125(22):681-5. PubMed ID: 10874894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Polymyalgia rheumatica and giant cell arteritis].
    Jipp P; Fehring K
    Dtsch Med Wochenschr; 1984 Oct; 109(43):1635-8. PubMed ID: 6489177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antimitochondrial Antibodies and Primary Biliary Cholangitis in Patients with Polymyalgia Rheumatica/Giant Cell Arteritis.
    Manzo C; Maslinska M; Castagna A; Hysa E; Merante A; Milchert M; Gravina T; Sargin B; Natale M; Ruberto C; Ruotolo G
    Medicina (Kaunas); 2021 Apr; 57(4):. PubMed ID: 33917502
    [No Abstract]   [Full Text] [Related]  

  • 13. Low serum levels of DHEAS in untreated polymyalgia rheumatica/giant cell arteritis.
    Narváez J; Bernad B; Díaz Torné C; Momplet JV; Montpel JZ; Nolla JM; Valverde-García J
    J Rheumatol; 2006 Jul; 33(7):1293-8. PubMed ID: 16783861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary Care Vasculitis: Polymyalgia Rheumatica and Giant Cell Arteritis.
    Pioro MH
    Prim Care; 2018 Jun; 45(2):305-323. PubMed ID: 29759126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymyalgia rheumatica and temporal arteritis: a retrospective study of 111 patients.
    Mertens JC; Willemsen G; Van Saase JL; Bolk JH; Dijkmans BA
    Clin Rheumatol; 1995 Nov; 14(6):650-5. PubMed ID: 8608683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Secondary (AA-type) amyloidosis in patients with polymyalgia rheumatica.
    Escribá A; Morales E; Albizúa E; Herrero JC; Ortuño T; Carreño A; Dominguez-Gil B; Praga M
    Am J Kidney Dis; 2000 Jan; 35(1):137-40. PubMed ID: 10620555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymyalgia rheumatica.
    Fernandez-Herlihy L
    Semin Arthritis Rheum; 1972; 1(3):236-45. PubMed ID: 4563397
    [No Abstract]   [Full Text] [Related]  

  • 18. [Polymyalgia rheumatica and its treatment].
    Mumenthaler M
    Dtsch Med Wochenschr; 1974 Sep; 99(36):1774-5. PubMed ID: 4141305
    [No Abstract]   [Full Text] [Related]  

  • 19. [Giant cell arteritis and polymyalgia rheumatica presenting as subclavian artery obstruction].
    Sato M; Takeda A; Hagiwara S; Mochizuki M; Minato N; Saito K; Kano S
    Ryumachi; 1993 Aug; 33(4):330-4. PubMed ID: 8235915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognosis and management of polymyalgia rheumatica.
    Jones JG; Hazleman BL
    Ann Rheum Dis; 1981 Feb; 40(1):1-5. PubMed ID: 7469518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.